Your browser doesn't support javascript.
loading
A Randomized, Double-Blind, Single-Dose, Crossover Study to Demonstrate the Bioequivalence of 2 Formulations of Albiglutide in Healthy Adult Participants.
Shaddinger, Bonnie C; Vlasakakis, Georgios; Soffer, Joseph; Thorpe, Karl M; Hatch, Daniel; Nino, Antonio J.
Afiliação
  • Shaddinger BC; Clinical Development, GlaxoSmithKline, Collegeville, PA, USA.
  • Vlasakakis G; Research and Development, GlaxoSmithKline, London, UK.
  • Soffer J; Clinical Development, GlaxoSmithKline, Collegeville, PA, USA.
  • Thorpe KM; Pharma Research and Development, GlaxoSmithKline, Stockley Park, UK.
  • Hatch D; Biostatistics, Early Development Services, PPD Development Inc, Wilmington, NC, USA.
  • Nino AJ; Clinical Development, GlaxoSmithKline, Collegeville, PA, USA.
Clin Pharmacol Drug Dev ; 8(3): 361-370, 2019 04.
Article em En | MEDLINE | ID: mdl-30063297
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeo 1 Semelhante ao Glucagon / Hipoglicemiantes Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeo 1 Semelhante ao Glucagon / Hipoglicemiantes Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article